Integra Lifesciences Holdings Stock Probability Of Bankruptcy

IART Stock

USD 23.00 0.07 0.31%

Integra LifeSciences' odds of distress is under 31% at this time. It has slight probability of undergoing some form of financial hardship in the near future. Probability of financial unrest prediction helps decision makers evaluate Integra LifeSciences' chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the Integra balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Integra LifeSciences Piotroski F Score and Integra LifeSciences Altman Z Score analysis.

Market Cap is likely to gain to about 1 B in 2024. Enterprise Value is likely to gain to about 442.9 M in 2024

Integra LifeSciences Holdings Company probability of financial unrest Analysis

Integra LifeSciences' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Integra LifeSciences Probability Of Bankruptcy

Less than 31%

Most of Integra LifeSciences' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integra LifeSciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Integra LifeSciences probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Integra LifeSciences odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Integra LifeSciences Holdings financial health.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.60)

Earnings Share

(0.09)

Revenue Per Share

20.23

Quarterly Revenue Growth

(0)

Return On Assets

0.0302

The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Integra Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Integra LifeSciences is extremely important. It helps to project a fair market value of Integra Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Integra LifeSciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Integra LifeSciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Integra LifeSciences' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Investments	Short Term Debt	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.94	0.83	0.86	0.96	0.99	0.96	0.97	0.68	0.02	0.86	0.86	-0.04	0.94	0.57	0.99	-0.67	0.89	0.87	0.17	-0.03	0.84	0.69	0.77	0.54
Total Stockholder Equity	0.97		0.84	0.87	0.82	0.92	0.92	0.96	0.92	0.7	0.05	0.85	0.77	-0.11	0.94	0.45	0.95	-0.52	0.79	0.91	0.16	-0.01	0.87	0.73	0.82	0.55
Net Debt	0.94	0.84		0.69	0.88	0.95	0.98	0.84	0.96	0.57	-0.03	0.8	0.9	0.08	0.88	0.68	0.96	-0.84	0.94	0.74	0.19	-0.07	0.72	0.49	0.56	0.48
Retained Earnings	0.83	0.87	0.69		0.71	0.74	0.78	0.86	0.71	0.88	-0.1	0.56	0.54	-0.37	0.82	0.41	0.79	-0.21	0.59	0.72	0.02	-0.15	0.7	0.88	0.85	0.76
Accounts Payable	0.86	0.82	0.88	0.71		0.93	0.86	0.78	0.85	0.48	-0.15	0.73	0.75	-0.02	0.88	0.56	0.87	-0.63	0.78	0.7	0.04	-0.19	0.72	0.44	0.49	0.48
Net Receivables	0.96	0.92	0.95	0.74	0.93		0.96	0.89	0.96	0.53	0.01	0.86	0.86	-0.01	0.96	0.59	0.97	-0.72	0.87	0.81	0.17	-0.03	0.8	0.5	0.59	0.46
Total Liab	0.99	0.92	0.98	0.78	0.86	0.96		0.93	0.98	0.65	0.01	0.85	0.9	0.02	0.92	0.64	0.99	-0.76	0.94	0.82	0.18	-0.04	0.8	0.63	0.71	0.52
Total Current Assets	0.96	0.96	0.84	0.86	0.78	0.89	0.93		0.88	0.69	0.0	0.81	0.81	-0.18	0.9	0.51	0.92	-0.51	0.83	0.84	0.03	-0.05	0.82	0.76	0.86	0.53
Intangible Assets	0.97	0.92	0.96	0.71	0.85	0.96	0.98	0.88		0.58	0.05	0.88	0.9	0.11	0.9	0.61	0.99	-0.81	0.93	0.84	0.27	0.0	0.81	0.56	0.66	0.45
Short Term Investments	0.68	0.7	0.57	0.88	0.48	0.53	0.65	0.69	0.58		-0.11	0.38	0.38	-0.2	0.62	0.26	0.66	-0.14	0.48	0.65	0.04	-0.16	0.6	0.87	0.82	0.82
Short Term Debt	0.02	0.05	-0.03	-0.1	-0.15	0.01	0.01	0.0	0.05	-0.11		0.31	0.03	0.32	0.05	0.24	0.03	-0.06	0.0	-0.01	0.5	1.0	-0.09	-0.04	-0.02	-0.1
Common Stock	0.86	0.85	0.8	0.56	0.73	0.86	0.85	0.81	0.88	0.38	0.31		0.9	0.21	0.8	0.59	0.87	-0.7	0.87	0.84	0.25	0.27	0.84	0.39	0.59	0.13
Long Term Debt	0.86	0.77	0.9	0.54	0.75	0.86	0.9	0.81	0.9	0.38	0.03	0.9		0.09	0.76	0.74	0.87	-0.84	0.98	0.76	0.17	-0.01	0.75	0.38	0.54	0.11
Treasury Stock	-0.04	-0.11	0.08	-0.37	-0.02	-0.01	0.02	-0.18	0.11	-0.2	0.32	0.21	0.09		-0.15	-0.13	0.04	-0.39	0.16	-0.04	-0.04	0.33	0.12	-0.29	-0.19	-0.2
Property Plant Equipment	0.94	0.94	0.88	0.82	0.88	0.96	0.92	0.9	0.9	0.62	0.05	0.8	0.76	-0.15		0.56	0.93	-0.56	0.77	0.83	0.25	0.01	0.76	0.57	0.63	0.56
Current Deferred Revenue	0.57	0.45	0.68	0.41	0.56	0.59	0.64	0.51	0.61	0.26	0.24	0.59	0.74	-0.13	0.56		0.58	-0.66	0.71	0.38	0.46	0.22	0.24	0.25	0.24	0.12
Good Will	0.99	0.95	0.96	0.79	0.87	0.97	0.99	0.92	0.99	0.66	0.03	0.87	0.87	0.04	0.93	0.58		-0.73	0.9	0.86	0.2	-0.02	0.84	0.63	0.72	0.54
Net Tangible Assets	-0.67	-0.52	-0.84	-0.21	-0.63	-0.72	-0.76	-0.51	-0.81	-0.14	-0.06	-0.7	-0.84	-0.39	-0.56	-0.66	-0.73		-0.86	-0.48	-0.31	-0.04	-0.47	-0.1	-0.2	-0.08
Long Term Debt Total	0.89	0.79	0.94	0.59	0.78	0.87	0.94	0.83	0.93	0.48	0.0	0.87	0.98	0.16	0.77	0.71	0.9	-0.86		0.76	0.13	-0.04	0.77	0.46	0.6	0.24
Capital Surpluse	0.87	0.91	0.74	0.72	0.7	0.81	0.82	0.84	0.84	0.65	-0.01	0.84	0.76	-0.04	0.83	0.38	0.86	-0.48	0.76		0.23	-0.06	0.93	0.58	0.76	0.33
Deferred Long Term Liab	0.17	0.16	0.19	0.02	0.04	0.17	0.18	0.03	0.27	0.04	0.5	0.25	0.17	-0.04	0.25	0.46	0.2	-0.31	0.13	0.23		0.5	-0.08	-0.02	-0.08	0.02
Short Long Term Debt	-0.03	-0.01	-0.07	-0.15	-0.19	-0.03	-0.04	-0.05	0.0	-0.16	1.0	0.27	-0.01	0.33	0.01	0.22	-0.02	-0.04	-0.04	-0.06	0.5		-0.14	-0.1	-0.08	-0.13
Long Term Investments	0.84	0.87	0.72	0.7	0.72	0.8	0.8	0.82	0.81	0.6	-0.09	0.84	0.75	0.12	0.76	0.24	0.84	-0.47	0.77	0.93	-0.08	-0.14		0.55	0.76	0.3
Net Invested Capital	0.69	0.73	0.49	0.88	0.44	0.5	0.63	0.76	0.56	0.87	-0.04	0.39	0.38	-0.29	0.57	0.25	0.63	-0.1	0.46	0.58	-0.02	-0.1	0.55		0.93	0.75
Net Working Capital	0.77	0.82	0.56	0.85	0.49	0.59	0.71	0.86	0.66	0.82	-0.02	0.59	0.54	-0.19	0.63	0.24	0.72	-0.2	0.6	0.76	-0.08	-0.08	0.76	0.93		0.57
Capital Stock	0.54	0.55	0.48	0.76	0.48	0.46	0.52	0.53	0.45	0.82	-0.1	0.13	0.11	-0.2	0.56	0.12	0.54	-0.08	0.24	0.33	0.02	-0.13	0.3	0.75	0.57

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Integra LifeSciences

Based on the latest financial disclosure, Integra LifeSciences Holdings has a Probability Of Bankruptcy of 31.0%. This is 28.39% lower than that of the Health Care Equipment & Supplies sector and 24.7% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 22.17% higher than that of the company.

Integra Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integra LifeSciences' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integra LifeSciences could also be used in its relative valuation, which is a method of valuing Integra LifeSciences by comparing valuation metrics of similar companies.

Integra LifeSciences is currently under evaluation in probability of bankruptcy category among its peers.

Integra LifeSciences Main Bankruptcy Drivers

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.0152	0.037	0.0447	0.0464	0.0179	0.0188
Asset Turnover	0.37	0.47	0.46	0.38	0.41	0.4
Net Debt	1.3B	1.2B	1.1B	1.2B	1.4B	1.5B
Total Current Liabilities	331.3M	401.0M	340.0M	320.9M	307.0M	158.9M
Non Current Liabilities Total	1.6B	1.7B	1.8B	1.8B	1.9B	2.0B
Total Assets	3.3B	3.6B	3.8B	3.9B	3.8B	4.0B
Total Current Assets	858.2M	1.2B	1.2B	1.2B	1.1B	1.1B
Total Cash From Operating Activities	373.7M	203.8M	312.4M	264.5M	140.0M	102.4M

Integra LifeSciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Integra LifeSciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Integra LifeSciences' managers, analysts, and investors.

Environmental

Governance

Social

Integra Fundamentals

	Return On Equity	-0.0042
	Return On Asset	0.0302
	Profit Margin	(0) %
	Operating Margin	0.07 %
	Current Valuation	3.48 B
	Shares Outstanding	77.16 M
	Shares Owned By Insiders	3.21 %
	Shares Owned By Institutions	93.14 %
	Number Of Shares Shorted	5.18 M
	Price To Earning	26.94 X
	Price To Book	1.16 X
	Price To Sales	1.13 X
	Revenue	1.54 B
	Gross Profit	982.03 M
	EBITDA	383.57 M
	Net Income	67.74 M
	Cash And Equivalents	451.52 M
	Cash Per Share	5.41 X
	Total Debt	1.68 B
	Debt To Equity	1.03 %
	Current Ratio	3.85 X
	Book Value Per Share	19.73 X
	Cash Flow From Operations	139.96 M
	Short Ratio	7.11 X
	Earnings Per Share	(0.09) X
	Price To Earnings To Growth	0.77 X
	Target Price	28.11
	Number Of Employees	3.95 K
	Beta	1.08
	Market Capitalization	1.77 B
	Total Asset	3.78 B
	Retained Earnings	946.86 M
	Working Capital	751.06 M
	Current Asset	438.5 M
	Current Liabilities	139.13 M
	Net Asset	3.78 B

About Integra LifeSciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Integra LifeSciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integra LifeSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integra LifeSciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Integra Lifesciences Holdings Stock Probability Of Bankruptcy

Integra LifeSciences Holdings Company probability of financial unrest Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Integra LifeSciences Probability Of Bankruptcy

Integra Probability Of Bankruptcy Driver Correlations

Integra Probability Of Bankruptcy Peer Comparison

Integra LifeSciences Main Bankruptcy Drivers

Integra LifeSciences ESG Sustainability

Integra Fundamentals

About Integra LifeSciences Fundamental Analysis

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Integra Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY